FOSUN ORINOVE PHARMATECH INC has a total of 15 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are CHAKRAVARTY SARVAJIT, ABBISKO THERAPEUTICS CO LTD and YAMANOUCHI PHARMACEUTICALS CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | Japan | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Zeng Qingping | 13 |
#2 | Patterson John Bruce | 7 |
#3 | Wu Zhipeng | 6 |
#4 | Yang Yun | 6 |
#5 | Toro Andras | 5 |
#6 | Wade Warren Stanfield | 5 |
#7 | Zubovics Zoltan | 5 |
#8 | Greene Stephanie | 5 |
#9 | Patterson John | 5 |
#10 | Zoltan Zubovics | 2 |
Publication | Filing date | Title |
---|---|---|
AU2019311031A1 | IRE1α inhibitor in combination with cancer therapeutic agent for cancer treatment | |
WO2020087522A1 | IRE1α inhibitor in combination with cancer therapeutic agent for cancer treatment | |
WO2020019107A1 | IRE1α INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENT |